InvestSMART

Imugene Limited (ASX: IMU) - Announcements

- Current share price for IMU : $0.039

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$21 Appendix 2A 24 Nov 2020 7:39PM $0.125 $0.039 fallen by 68.80%
$21 Proposed issue of Securities - IMU 24 Nov 2020 7:27PM $0.125 $0.039 fallen by 68.80%
$21 Results of Meeting 24 Nov 2020 12:15PM $0.133 $0.039 fallen by 70.57%
$21 Investor Presentation 24 Nov 2020 8:24AM $0.115 $0.039 fallen by 66.09%
$21 AGM Presentation 24 Nov 2020 8:24AM $0.115 $0.039 fallen by 66.09%
$21 Imugene HER Vaxx shows positive Overall Survival in trial 23 Nov 2020 8:21AM $0.100 $0.039 fallen by 61%
$21 Release of Securities from Escrow 18 Nov 2020 11:54AM $0.105 $0.039 fallen by 62.86%
$21 Appendix 2A 17 Nov 2020 7:16PM $0.100 $0.039 fallen by 61%
$21 Proposed issue of Securities - IMU 17 Nov 2020 7:00PM $0.100 $0.039 fallen by 61%
$21 Proposed issue of Securities - IMU 10 Nov 2020 6:16PM $0.062 $0.039 fallen by 37.10%
$21 Appendix 2A 10 Nov 2020 6:08PM $0.062 $0.039 fallen by 37.10%
$21 Appendix 2A 4 Nov 2020 6:10PM $0.056 $0.039 fallen by 30.36%
$21 Proposed issue of Securities - IMU 4 Nov 2020 5:24PM $0.056 $0.039 fallen by 30.36%
$21 Becoming a substantial holder 4 Nov 2020 1:59PM $0.058 $0.039 fallen by 32.76%
$21 Letter to IMUOA Optionholders 2 Nov 2020 5:35PM $0.056 $0.039 fallen by 30.36%
$21 Imugene Receives FDA IND Approval for PD1-VAXX Trial in USA 2 Nov 2020 8:51AM $0.056 $0.039 fallen by 30.36%
$21 Appendix 4C - quarterly 27 Oct 2020 9:47AM $0.058 $0.039 fallen by 32.76%
$21 Appendix 2A 22 Oct 2020 6:50PM $0.061 $0.039 fallen by 36.07%
$21 Proposed issue of Securities - IMU 22 Oct 2020 6:43PM $0.061 $0.039 fallen by 36.07%
$21 Notice of Annual General Meeting/Proxy Form 21 Oct 2020 5:04PM $0.060 $0.039 fallen by 35%
$21 Appendix 2A 15 Oct 2020 5:06PM $0.054 $0.039 fallen by 27.78%
$21 Proposed issue of Securities - IMU 15 Oct 2020 4:53PM $0.054 $0.039 fallen by 27.78%
$21 Appendix 2A 7 Oct 2020 7:30PM $0.056 $0.039 fallen by 30.36%
$21 Proposed issue of Securities - IMU 7 Oct 2020 7:11PM $0.056 $0.039 fallen by 30.36%
$21 Imugene Immunotherapy Combination Patent Granted in US 2 Oct 2020 8:37AM $0.051 $0.039 fallen by 23.53%

676 - 700 of 1204 results

Page 28 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.